Mindbio pitches AI voice drug tests to miners

Executive Summary

• Mindbio Therapeutics Corp. is engaging with mining and health executives in South America to explore the deployment of its AI voice-based drug and alcohol detection technology.
• The company is positioning its proprietary technology as a non-invasive, scalable alternative to traditional testing methods (saliva, urine, blood, breath) for the mining industry, where such testing is government-mandated.
• CEO Justin Hanka reports significant commercial interest from the region, citing a massive market opportunity to disrupt current testing processes globally.

Key Details

• Target Market: Mining industry in South America, specifically targeting "at the gate" screening for multiple substances including alcohol, hallucinogens, amphetamines, cocaine, and cannabis.
• Technology Capabilities: The core technology predicts intoxication with hallucinogens and alcohol by analyzing voice patterns via a proprietary AI platform. The company plans to expand algorithms to detect other prohibited drugs that are difficult to detect at scale.
• Market Context (Chile):
  • Alcohol consumption among mining workers exceeds 75%.
  • Problem drinkers account for over 40% of the workforce.
  • Drug use is estimated at 9% among the 200,000+ mining workers in Chile.
• Industry Problem: Current testing is described as slow, expensive, time-consuming, and personally invasive. One accident can cost a mining company hundreds of millions in delayed production, union boycotts, and insurance/medical expenses.
• Safety Statistics: Internationally, 20-25% of occupational accidents are linked to substance use.
• Strategic Goal: To develop and deploy an appropriate solution for the South American region, which represents a major opportunity for global disruption of drug and alcohol testing.

Notable Quotes

• Justin Hanka, CEO: "We are delighted by the commercial interest in our core technology by the mining industry and will work with our counterparts in South America to develop and deploy an appropriate solution for the region which represents a massive opportunity for the company to disrupt drug and alcohol testing processes in the mining industry globally."